ARCC vs EVR

ARCC presents a conflicting profile: while it trades at a discount to book value (P/B 0.93) and below its Graham Number ($28.81), its fundamental health is deteriorating. The Piotroski F-Score of 2/9 indicates weak financial health, compounded by a concerning earnings decline of -24.90% YoY. Most critically, the dividend payout ratio of 103.23% suggests the current 10.32% yield is unsustainable without eroding capital or utilizing reserves. Despite analyst 'Buy' ratings, the combination of negative growth and poor deterministic health scores warrants a cautious approach.

Evercore exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and exceptional growth metrics. While the stock trades at a significant premium to its Graham Number ($129.12), it remains undervalued relative to its growth-based intrinsic value of $414.48. The company's powerhouse profitability, highlighted by a 30.07% ROE and consistent earnings beats over 25 quarters, outweighs current bearish technical trends and insider selling. The forward P/E of 15.05 suggests the market is beginning to price in continued earnings expansion.